"Instytut Centrum Zdrowia Matki Polki – ICZMP w Łodzi jest jednym z największych wysokospecjalistycznych ośrodków medycznych w Polsce. Placówka składa się z dwóch części: Ginekologiczno-Położniczej oraz Pediatrycznej. Jest wiodącym ośrodkiem referencyjnym perinatologicznym, ginekologicznym i pediatrycznym. Ze względu na swój wielodyscyplinarny charakter, zapewnia wszechstronną opiekę nad kobietami w ciąży powikłanej cukrzycą, nadciśnieniem tętniczym, padaczką, chorobami serca, czy infekcjami. W Instytucie diagnozowane i leczone są najtrudniejsze przypadki patologii ginekologicznych."

During the past decade, Instytut Centrum Zdrowia Matki Polki conducted 48 clinical trials. In the 10-year time frame, 48 clinical trials started and 15 clinical trials were completed, i.e. on average, 31.3% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 12 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Instytut Centrum Zdrowia Matki Polki" #1 sponsor was "Shire" with 6 trials, followed by "Amgen" with 5 trials sponsored, "Polish Mother Memorial Hospital Research Institute" with 5 trials sponsored, "Celgene" with 4 trials sponsored and "Mannkind Corporation" with 4 trials sponsored. Other sponsors include 33 different institutions and companies that sponsored additional 34 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instytut Centrum Zdrowia Matki Polki" #1 collaborator was "Novartis" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator and "German Breast Group" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Instytut Centrum Zdrowia Matki Polki" are "Ulcerative Colitis" (5 trials), "Crohn Disease" (4 trials), "Crohn's Disease" (4 trials), "Body Indication" (2 trials) and "Bottle Feeding" (2 trials). Many other conditions were trialed in "Instytut Centrum Zdrowia Matki Polki" in a lesser frequency.

Most popular intervention types in "Instytut Centrum Zdrowia Matki Polki" are "Drug" (49 trials), "Other" (11 trials), "Procedure" (5 trials), "Biological" (4 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Ontamalimab" (4 trials), "Ozanimod" (3 trials), "Paclitaxel" (3 trials) and "ARO-APOC3" (2 trials). Other intervention names were less common.

The vast majority of trials in "Instytut Centrum Zdrowia Matki Polki" are 55 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Instytut Centrum Zdrowia Matki Polki". undefined are not yet recruiting, 26 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Instytut Centrum Zdrowia Matki Polki, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Instytut Centrum Zdrowia Matki Polki, 3 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".

Instytut Centrum Zdrowia Matki Polki has several departments that took part in Clinical trials: "Instytut "Centrum Zdrowia Matki Polki; Klinika Pediatrii i Immunologii i Nefrologii" - 3 trials, "Instyt. Centrum Zdrowia Matki Polki; Klinika Chirurgii Onk. Chorób Piersi z Podod. Onko Klinicznej" - 2 trials